Skip to main content
Alissa Cooper on Muck Rack

Alissa Cooper

Boston
As seen in: Medium, Nature, Wiley Online Library, Cell Press, Network World, PYMNTS, HemOnc Today, Texas Medical Center, CircleID, OncLive and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alissa

Contact Alissa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Author Correction: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

|
By Lauren Averett Byers, Byoung Chul Cho, Alissa Cooper, Anne C. Chiang, Ji-Youn Han, Muhammad M. Furqan, Afshin Dowlati, Daniel Morgensztern, Kyriakos P. Papadopoulos, Noura J. Choudhury, Maria Vieito, Jair Bar, Joo-Hang Kim, Wallace Akerley, Tae Kim, Young-Chul Kim, Luis Paz-Ares, Myung-Ju Ahn, Hiroshi Yokouchi, Darius Meiman, Wijith Munasinghe, Oluwadamilola Ogunyankin, Nadine S. Jahchan, Song Wang, Cristiano Ferlini, Randy Robinson, Frederick J. Kohlhapp, Tammy Palenski, Guillermo Rivell, Pooja Hingorani, Sreenivasa Chandana
| Nature Verified
Correction to: Nature Medicine https://doi.org/10.1038/s41591-026-04452-0, published online 1 June 2026. In the version of this article initially published, ref. 10 was cited twice and has been replaced by an omitted reference (Faivre E. J. et al. Cancer Res. https://doi.org/10.1158/1538-7445.AM2024-3148 (2024)), now cited as ref.
Open in Who Shared Issue with article?

Designing Europe’s Search Data Sharing Rules for Competition in the AI Era

|
By Alissa Cooper, Zander Arnao
| Tech Policy Press
Brussels, Belgium - November 3, 2022; European Flags in front of the European Commission Headquarters building. Shutterstock Google’s dominance in search is increasingly under scrutiny as regulators on both sides of the Atlantic consider whether new rules could reshape competition in the AI-driven search era.
Open in Who Shared View Duplicates (2) Issue with article?

SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

|
By Lauren Averett Byers, Byoung Chul Cho, Alissa Cooper, Anne C. Chiang, Ji-Youn Han, Muhammad M. Furqan, Afshin Dowlati, Daniel Morgensztern, Kyriakos P. Papadopoulos, Noura J. Choudhury, Maria Vieito, Jair Bar, Joo-Hang Kim, Wallace Akerley, Tae Kim, Young-Chul Kim, Luis Paz-Ares, Myung-Ju Ahn, Hiroshi Yokouchi, Darius Meiman, Wijith Munasinghe, Oluwadamilola Ogunyankin, Nadine S. Jahchan, Song Wang, Cristiano Ferlini, Randy Robinson, Frederick J. Kohlhapp, Tammy Palenski, Guillermo Rivell, Pooja Hingorani, Sreenivasa Chandana
| Nature Verified
Abstract Seizure-related homolog 6 (SEZ6) is expressed in small cell lung cancer (SCLC) and neuroendocrine neoplasms. In an open label, phase 1 trial, ABBV-706, an antibody−drug conjugate with a SEZ6-directed antibody linked to topoisomerase-1 inhibitor (Top1i), was administered intravenously every 3 weeks (Q3W) to 288 patients with advanced solid tumors; 240 received monotherapy, including 124 with relapsed/refractory (R/R) SCLC.
Open in Who Shared Issue with article?
See all 24 licensed articles (62 Total)